Further available immunization option to prevent pneumococcal disease

In their recent review, Charles Feldman and Ronald Anderson provide an overview of various clinical aspects of pneumococcal infections. We would like to complete this report by providing some additional information on a widely-used immunization option, which was not originally mentioned in the artic...

Descripción completa

Detalles Bibliográficos
Autores principales: Vojtek, Ivo, Hoet, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2015
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376167/
https://www.ncbi.nlm.nih.gov/pubmed/25866621
http://dx.doi.org/10.12688/f1000research.5990.1
Descripción
Sumario:In their recent review, Charles Feldman and Ronald Anderson provide an overview of various clinical aspects of pneumococcal infections. We would like to complete this report by providing some additional information on a widely-used immunization option, which was not originally mentioned in the article. The protein D pneumococcal conjugate vaccine (PHiD-CV) has been pre-approved by WHO and its impact is supported by real-life data from the regions of its use.

Ejemplares similares